Pounce Thrombectomy System for clots in peripheral arteries
Reviews Pounce device clot removal in peripheral arterial disease.
Key facts
- Who runs it
- SurModics, Inc.
- Where
- Austin, Baton Rouge, Cleveland, Greenville, Minneapolis, Munster, Nashville, Peoria, and Sioux Falls, United StatesSee the 9 sites
- Trial code
- Registry title
- Pounce™ Thrombectomy System Retrospective Registry
- Status
- Recruiting
- People taking part
- 500 people, planned
- Started
- 18 Apr 2023
- Planned end
- 31 Jul 2026
- Type of study
- Observational
- Treatments tested
- Pounce Thrombectomy System
- Record updated
- 11 September 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who already had a procedure inside a blood vessel where the Pounce Thrombectomy System was tried. This device removes clots from arteries in the limbs. The study looks back at their records.
- Age
- 18 Years and older
- Sex
- All
- Disease stage
- Peripheral arterial disease or acute limb ischemia (a sudden loss of blood flow to an arm or leg), with clots in the limb arteries.
- Earlier treatment
- People must have had a procedure inside the blood vessels where the Pounce Thrombectomy System was attempted.
Main reasons for not taking part
- People under the age of 18 years cannot join.
- People who did not give informed consent cannot join, unless a consent waiver is in place.
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- Subject underwent an endovascular intervention where the Pounce Thrombectomy System was attempted
- Subject is willing and able to provide informed consent prior to the collection of study data or a consent waiver is in place
Who cannot take part
- Subject is under the age of 18 years
Where in United States
- Ascension SetonAustin, United StatesContact: Clinical Program ManagerTaking people
- Baton Rouge General Medical CenterBaton Rouge, United StatesContact: Clinical Program ManagerTaking people
- Cleveland ClinicCleveland, United StatesContact: Clinical Program ManagerTaking people
- Prisma Health-UpstateGreenville, United StatesContact: Clinical Program ManagerTaking people
- Allina HealthMinneapolis, United StatesContact: Clinical Program ManagerNo longer taking part
- Community HospitalMunster, United StatesContact: Clinical Program ManagerNo longer taking part
- Vanderbilt University Medical CenterNashville, United StatesContact: Clinical Program ManagerTaking people
- OSF St Francis Medical CenterPeoria, United StatesContact: Clinical Program ManagerTaking people
- North Central HeartSioux Falls, United StatesContact: Clinical Program ManagerTaking people
About the trial
What the trial wants to find out
The PROWL registry is an open-label retrospective, multi-center, US study of the Surmodics™ Pounce™ Thrombectomy System for the non-surgical removal of emboli and thrombi in the peripheral arterial vasculature.
The group in the trial
- Retrospective
All subjects in whom the Pounce Thrombectomy System was attempted will be included.
Treatment: Pounce Thrombectomy System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pounce™ Thrombectomy System Retrospective Registry
- Plain-language title
- Pounce Thrombectomy System for clots in peripheral arteriesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 11 September 2025